A Study of Fostamatinib in Subjects With Impaired Kidney Function
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
A 2 stage study to evaluate the amount of fostamatinib in the blood and urine in subjects
with impaired kidney (renal) function compared with healthy volunteers with normal renal
function. Stage 1 will include healthy subjects and subjects with end stage renal disease,
while Stage, 2 may include subjects with mild, moderate and/or severe renal impairment
dependent on the outcome of Stage 1. The study will also evaluate safety and tolerability in
subjects with renal impairment.